Molecular profiling of lymphoma [1] (multiple letters)

New England Journal of Medicine

Volumn 347, Issue 17, 2002, Pages 1376-1377

  Akhtar, Saad ^a   Copur, M Sitki ^a   Ledakis, Petek ^a   Bolton, Mark ^a   Staudt, Louis M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; MESSENGER RNA; PROTEIN BCL 2; ANTINEOPLASTIC ANTIBIOTIC;

B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHROMOSOME TRANSLOCATION; DRUG RESPONSE; GENE EXPRESSION; HUMAN; KAPLAN MEIER METHOD; LETTER; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; GENE EXPRESSION PROFILING; GENE TRANSLOCATION; GENETICS; LARGE CELL LYMPHOMA; METHODOLOGY; NOTE; OUTCOME ASSESSMENT; PROTO ONCOGENE; MORTALITY;

GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, BCL-2; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; TRANSLOCATION, GENETIC; ANTIBIOTICS, ANTINEOPLASTIC; RESEARCH DESIGN; SURVIVAL RATE;

EID: 0037167984     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200210243471716     Document Type: Letter

References (0)